Australia markets closed

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
154.53-0.10 (-0.06%)
At close: 04:00PM EDT
154.53 0.00 (0.00%)
After hours: 05:20PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close154.63
Open157.25
Bid148.95 x 800
Ask157.50 x 800
Day's range150.09 - 158.00
52-week range137.21 - 327.32
Volume242,038
Avg. volume512,503
Market cap8.566B
Beta (5Y monthly)0.98
PE ratio (TTM)61.10
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance

    —Record revenue of $206.4 million for the quarter, and year-over-year growth of 45% as reported and 48% at constant currency —Organic revenue growth of 44% for the quarter and base business growth of 37% —Growth driven by combination of base business strength, COVID-related demand, and acquisition revenue WALTHAM, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results f

  • GlobeNewswire

    Repligen to Report First Quarter 2022 Financial Results

    Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDTWALTHAM, Mass., April 13, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2022 financial results on Wednesday, April 27, 2022. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. EDT to discuss business updates and financial results for the three- month reporting period ended March 31, 2

  • GlobeNewswire

    Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum

    WALTHAM, Mass., March 18, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the KeyBanc Life Science and MedTech Investor Forum being held March 22-23, 2022. Tony J. Hunt, President & Chief Executive Officer, will participate in a fireside chat on Tuesday, March 22, at 9:45 a.m. EDT. A live webcast of the presentation will be accessible through Repligen’s Investor